Cell Source, Inc.: 10-K filed 2023-08-08
What Cell Source, Inc. reported in its annual report filed 2023-08-08 (fiscal FY 2022): 27 published measures, 55 facts as tagged in accession 0001493152-23-027069.
This filing
- Form
- 10-K (annual report)
- Filed
- 2023-08-08
- Fiscal period
- fiscal FY 2022
- Accession
- 0001493152-23-027069 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 409,845 | USD | |
| At 2021-12-31 | 313,767 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 13,043,740 | USD | |
| At 2021-12-31 | 10,139,902 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | -12,633,895 | USD | |
| At 2021-12-31 | -9,826,135 | USD | |
| At 2020-12-31 | -7,947,382 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 222,665 | USD | |
| At 2021-12-31 | 93,095 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -5,167,748 | USD | 365 |
| 2021-01-01 to 2021-12-31 | -5,472,435 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -3,138,686 | USD | 365 |
| 2021-01-01 to 2021-12-31 | -3,378,682 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 3,268,256 | USD | 365 |
| 2021-01-01 to 2021-12-31 | 3,226,658 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | -36,346,176 | USD | |
| At 2021-12-31 | -31,178,428 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 34,836,169 | shares | 365 |
| 2021-01-01 to 2021-12-31 | 33,116,729 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 34,836,169 | shares | 365 |
| 2021-01-01 to 2021-12-31 | 33,116,729 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -0.18 | USD/shares | 365 |
| 2021-01-01 to 2021-12-31 | -0.19 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -0.18 | USD/shares | 365 |
| 2021-01-01 to 2021-12-31 | -0.19 | USD/shares | 365 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 77,887 | USD | 365 |
| 2021-01-01 to 2021-12-31 | 419,401 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -4,175,333 | USD | 365 |
| 2021-01-01 to 2021-12-31 | -4,018,572 | USD | 365 |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 680,325 | USD | |
| At 2021-12-31 | 223,041 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 4,175,333 | USD | 365 |
| 2021-01-01 to 2021-12-31 | 4,018,572 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 1,938,173 | USD | 365 |
| 2021-01-01 to 2021-12-31 | 1,273,352 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 36,081,758 | shares | |
| At 2021-12-31 | 34,360,546 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 23,674,354 | USD | |
| At 2021-12-31 | 21,316,318 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-12-31 | 1,485,857 | USD | |
| At 2021-12-31 | 1,097,021 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -5,167,748 | USD | 365 |
| 2021-01-01 to 2021-12-31 | -5,472,434 | USD | 365 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -6,325,234 | USD | 365 |
| 2021-01-01 to 2021-12-31 | -6,445,640 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 2,179,160 | USD | 365 |
| 2021-01-01 to 2021-12-31 | 2,695,164 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -992,415 | USD | 365 |
| 2021-01-01 to 2021-12-31 | -1,453,863 | USD | 365 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -754,660 | USD | 365 |
| 2021-01-01 to 2021-12-31 | -1,771,902 | USD | 365 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 19,898 | USD | 365 |
| 2021-01-01 to 2021-12-31 | 20,768 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 457,284 | USD | 365 |
| 2021-01-01 to 2021-12-31 | 29,946 | USD | 365 |
Inspect the source
- Entity
- Cell Source, Inc. / CIK 0001569340
- Captured
- 2026-09-20T09:20:59.488Z
- SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))